{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T23:27:22Z","timestamp":1794612442011,"version":"4.9.1"},"reference-count":223,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 NS36126"],"award-info":[{"award-number":["R01 NS36126"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5R01MH121402"],"award-info":[{"award-number":["5R01MH121402"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 NS126089"],"award-info":[{"award-number":["R01 NS126089"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI145542"],"award-info":[{"award-number":["R01AI145542"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["2R01 NS034239"],"award-info":[{"award-number":["2R01 NS034239"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI158160"],"award-info":[{"award-number":["R01AI158160"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006518","name":"University of Nebraska Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006518","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.isci.2026.114988","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:38:03Z","timestamp":1770770283000},"page":"114988","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["CAR Treg therapies for neurodegenerative diseases"],"prefix":"10.1016","volume":"29","author":[{"given":"Daniel N.","family":"Stein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard E.","family":"Gendelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.114988_bib1","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1182\/blood.2023021221","article-title":"CAR T-cell therapy in multiple myeloma: mission accomplished?","volume":"143","author":"Rasche","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.isci.2026.114988_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.currproblcancer.2021.100826","article-title":"CAR T-cell therapy for B-cell lymphoma","volume":"46","author":"Denlinger","year":"2022","journal-title":"Curr. Probl. Cancer"},{"key":"10.1016\/j.isci.2026.114988_bib3","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.medj.2024.03.002","article-title":"CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis","volume":"5","author":"Fischbach","year":"2024","journal-title":"Med"},{"key":"10.1016\/j.isci.2026.114988_bib4","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1038\/s41591-022-02017-5","article-title":"Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus","volume":"28","author":"Mackensen","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2026.114988_bib5","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1136\/ard-2023-223952","article-title":"Treatment of a patient with severe systemic sclerosis (SSc) using CD19-targeted CAR T cells","volume":"82","author":"Bergmann","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.isci.2026.114988_bib6","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJMoa2308917","article-title":"CD19 CAR T-cell therapy in autoimmune disease - a case series with follow-up","volume":"390","author":"Muller","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2026.114988_bib7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41571-023-00832-4","article-title":"CAR T cell therapy for patients with solid tumours: key lessons to learn and unlearn","volume":"21","author":"Albelda","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.isci.2026.114988_bib8","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/imr.13254","article-title":"Eras of designer Tregs: Harnessing synthetic biology for immune suppression","volume":"320","author":"Tuomela","year":"2023","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.isci.2026.114988_bib9","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1126\/science.aau2688","article-title":"T(reg) cells-the next frontier of cell therapy","volume":"362","author":"Bluestone","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.isci.2026.114988_bib10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41434-022-00358-x","article-title":"Preclinical assessment of antigen-specific chimeric antigen receptor regulatory T cells for use in solid organ transplantation","volume":"30","author":"Proics","year":"2023","journal-title":"Gene Ther."},{"key":"10.1016\/j.isci.2026.114988_bib11","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1111\/ajt.17063","article-title":"Anti-HLA-A2-CAR Tregs prolong vascularized mouse heterotopic heart allograft survival","volume":"22","author":"Wagner","year":"2022","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.isci.2026.114988_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.05.017","article-title":"Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetes","volume":"103","author":"Tenspolde","year":"2019","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.isci.2026.114988_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1207108","article-title":"Regulatory T cells targeting a pathogenic MHC class II: Insulin peptide epitope postpone spontaneous autoimmune diabetes","volume":"14","author":"Obarorakpor","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.114988_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102961","article-title":"Flagellin-specific human CAR Tregs for immune regulation in IBD","volume":"134","author":"Boardman","year":"2023","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.isci.2026.114988_bib15","article-title":"IL23R-specific CAR Tregs for the treatment of Crohn's disease","volume":"19","author":"Cui","year":"2025","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.isci.2026.114988_bib16","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.3389\/fimmu.2017.01125","article-title":"Chimeric antigen receptor-redirected regulatory T cells suppress experimental allergic airway inflammation, a model of asthma","volume":"8","author":"Skuljec","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.114988_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adj9331","article-title":"Human OX40L-CAR-T(regs) target activated antigen-presenting cells and control T cell alloreactivity","volume":"16","author":"Rui","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.isci.2026.114988_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1284501","article-title":"Bibliometric analysis of global research trends on regulatory T cells in neurological diseases","volume":"14","author":"Gao","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.isci.2026.114988_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114229","article-title":"ALPK1 signaling pathway activation by HMGB1 drives microglial pyroptosis and ferroptosis and brain injury after acute ischemic stroke","volume":"149","author":"Du","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.isci.2026.114988_bib20","doi-asserted-by":"crossref","DOI":"10.1093\/jmcb\/mjac036","article-title":"NRF1-mediated microglial activation triggers high-altitude cerebral edema","volume":"14","author":"Wang","year":"2022","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.isci.2026.114988_bib21","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/j.neuron.2023.04.006","article-title":"Microglial-to-neuronal CCR5 signaling regulates autophagy in neurodegeneration","volume":"111","author":"Festa","year":"2023","journal-title":"Neuron"},{"key":"10.1016\/j.isci.2026.114988_bib22","doi-asserted-by":"crossref","first-page":"7845","DOI":"10.1007\/s12035-024-04075-x","article-title":"M2 microglia-derived exosomes protect against glutamate-induced HT22 cell injury via exosomal miR-124-3p","volume":"61","author":"Zhu","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.isci.2026.114988_bib23","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/s41419-021-04363-7","article-title":"Extracellular vesicles from hypoxia-preconditioned microglia promote angiogenesis and repress apoptosis in stroke mice via the TGF-beta\/Smad2\/3 pathway","volume":"12","author":"Zhang","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.isci.2026.114988_bib24","article-title":"Foxp3(+) regulatory T cells restrain Th1 response shielding the brain from lethal inflammatory damage during cryptococcal meningoencephalitis","author":"Li","year":"2025","journal-title":"Res. Sq."},{"key":"10.1016\/j.isci.2026.114988_bib25","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1111\/cns.14333","article-title":"Ultrasound reduces inflammation by modulating M1\/M2 polarization of microglia through STAT1\/STAT6\/PPARgamma signaling pathways","volume":"29","author":"Hsu","year":"2023","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.isci.2026.114988_bib26","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/nn.4338","article-title":"A polarizing question: do M1 and M2 microglia exist?","volume":"19","author":"Ransohoff","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.isci.2026.114988_bib27","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.114988_bib28","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12974-020-01891-5","article-title":"Microglia induce the transformation of A1\/A2 reactive astrocytes via the CXCR7\/PI3K\/Akt pathway in chronic post-surgical pain","volume":"17","author":"Li","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.isci.2026.114988_bib29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12964-022-01036-6","article-title":"Transplantation of A2 type astrocytes promotes neural repair and remyelination after spinal cord injury","volume":"21","author":"Chang","year":"2023","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.isci.2026.114988_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114338","article-title":"Distinct roles of A1\/A2 astrocytes in blood-brain barrier injury following cerebral I\/R via the ROCK\/NF-kappaB and STAT3 pathways","volume":"151","author":"Geng","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.isci.2026.114988_bib31","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1038\/s41467-018-07053-9","article-title":"Tissue-resident memory T cells populate the human brain","volume":"9","author":"Smolders","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.114988_bib32","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41586-018-0824-5","article-title":"Brain regulatory T cells suppress astrogliosis and potentiate neurological recovery","volume":"565","author":"Ito","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.114988_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2023.114451","article-title":"Recruitment of regulatory T cells with rCCL17 promotes M2 microglia\/macrophage polarization through TGFbeta\/TGFbetaR\/Smad2\/3 pathway in a mouse model of intracerebral hemorrhage","volume":"367","author":"Deng","year":"2023","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.isci.2026.114988_bib34","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1111\/cns.14161","article-title":"Regulatory T cells promote functional recovery after spinal cord injury by alleviating microglia inflammation via STAT3 inhibition","volume":"29","author":"Liu","year":"2023","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.isci.2026.114988_bib35","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.cyto.2014.10.028","article-title":"Depletion of Foxp3+ regulatory T cells increases severity of mechanical allodynia and significantly alters systemic cytokine levels following peripheral nerve injury","volume":"71","author":"Lees","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.isci.2026.114988_bib36","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","article-title":"Role of neuroinflammation in neurodegeneration development","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.isci.2026.114988_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1439125","article-title":"The role of inflammation in neurological disorders: a brief overview of multiple sclerosis, Alzheimer's, and Parkinson's disease'","volume":"15","author":"Cantero-Fortiz","year":"2024","journal-title":"Front. Neurol."},{"key":"10.1016\/j.isci.2026.114988_bib38","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1021\/cn2001238","article-title":"Isolated amyloid-beta(1-42) protofibrils, but not isolated fibrils, are robust stimulators of microglia","volume":"3","author":"Paranjape","year":"2012","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.isci.2026.114988_bib39","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13834","article-title":"Parkin regulates microglial NLRP3 and represses neurodegeneration in Parkinson's disease","volume":"22","author":"Yan","year":"2023","journal-title":"Aging Cell"},{"key":"10.1016\/j.isci.2026.114988_bib40","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1093\/brain\/awab103","article-title":"CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson's disease","volume":"144","author":"Williams","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.isci.2026.114988_bib41","doi-asserted-by":"crossref","first-page":"8294","DOI":"10.1002\/alz.14249","article-title":"Comparative brain metabolomics reveals shared and distinct metabolic alterations in Alzheimer's disease and progressive supranuclear palsy","volume":"20","author":"Batra","year":"2024","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.isci.2026.114988_bib42","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12974-023-02756-3","article-title":"HMGB1 mediates synaptic loss and cognitive impairment in an animal model of sepsis-associated encephalopathy","volume":"20","author":"Yin","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.isci.2026.114988_bib43","article-title":"Sustained Microglial Activation Promotes Synaptic Loss and Neuronal Dysfunction after Recovery from ZIKV Infection","volume":"25","author":"Kim","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.114988_bib44","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200372","article-title":"Dysregulation of the Kynurenine Pathway in Relapsing Remitting Multiple Sclerosis and Its Correlations With Progressive Neurodegeneration","volume":"12","author":"Staats Pires","year":"2025","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.isci.2026.114988_bib45","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adl3438","article-title":"LRRK2 regulates production of reactive oxygen species in cell and animal models of Parkinson's disease","volume":"16","author":"Keeney","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.isci.2026.114988_bib46","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6039171","article-title":"The role of immunosenescence in neurodegenerative diseases","volume":"2018","author":"Costantini","year":"2018","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.isci.2026.114988_bib47","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41586-023-06373-1","article-title":"cGAS-STING drives ageing-related inflammation and neurodegeneration","volume":"620","author":"Gulen","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.114988_bib48","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.celrep.2016.12.011","article-title":"Major shifts in glial regional identity are a transcriptional hallmark of human brain aging","volume":"18","author":"Soreq","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2026.114988_bib49","doi-asserted-by":"crossref","first-page":"6422","DOI":"10.1038\/s41467-025-61544-0","article-title":"Gut microbiota and brain-resident CD4(+) T cells shape behavioral outcomes in autism spectrum disorder","volume":"16","author":"Park","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.114988_bib50","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2167172","article-title":"Gut-derived beta-amyloid: Likely a centerpiece of the gut-brain axis contributing to Alzheimer's pathogenesis","volume":"15","author":"Jin","year":"2023","journal-title":"Gut Microbes"},{"key":"10.1016\/j.isci.2026.114988_bib51","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s12974-023-02986-5","article-title":"27-hydroxycholesterol causes cognitive deficits by disturbing Th17\/Treg balance and the related immune responses in mild cognitive impairment patients and C57BL\/6J mice","volume":"20","author":"Wang","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.isci.2026.114988_bib52","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nm.4086","article-title":"Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers","volume":"22","author":"Saito","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2026.114988_bib53","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.it.2025.02.010","article-title":"Foxp3(+)CD8(+) regulatory T cells: bona fide Tregs with cytotoxic function","volume":"46","author":"Luo","year":"2025","journal-title":"Trends Immunol."},{"key":"10.1016\/j.isci.2026.114988_bib54","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202149775","article-title":"Eomesodermin-expressing type 1 regulatory (EOMES(+) Tr1)-like T cells: Basic biology and role in immune-mediated diseases","volume":"53","author":"Geginat","year":"2023","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.isci.2026.114988_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/cells13110941","article-title":"Defining human regulatory T Cells beyond FOXP3: the need to combine phenotype with function","volume":"13","author":"Gootjes","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.isci.2026.114988_bib56","article-title":"Beyond FOXP3: a 20-year journey unravelling human regulatory T-cell heterogeneity","volume":"14","author":"Santosh Nirmala","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.114988_bib57","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/s41590-020-0694-5","article-title":"Foxp3: a genetic foundation for regulatory T cell differentiation and function","volume":"21","author":"Ramsdell","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.isci.2026.114988_bib58","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nri.2017.75","article-title":"The regulation of immune tolerance by FOXP3","volume":"17","author":"Lu","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.isci.2026.114988_bib59","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.it.2016.08.012","article-title":"Induced regulatory T cells: their development, stability, and applications","volume":"37","author":"Kanamori","year":"2016","journal-title":"Trends Immunol."},{"key":"10.1016\/j.isci.2026.114988_bib60","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.rdc.2023.06.009","article-title":"Expanding IPEX: inborn errors of regulatory T cells","volume":"49","author":"Wobma","year":"2023","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"10.1016\/j.isci.2026.114988_bib61","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.jaci.2019.11.043","article-title":"Treatment with rapamycin can restore regulatory T-cell function in IPEX patients","volume":"145","author":"Passerini","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.isci.2026.114988_bib62","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/s41584-021-00741-9","article-title":"Regulation of activated T cell survival in rheumatic autoimmune diseases","volume":"18","author":"Rosetti","year":"2022","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.isci.2026.114988_bib63","article-title":"Dysfunctions, molecular mechanisms, and therapeutic strategies of regulatory T cells in rheumatoid arthritis","volume":"12","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.isci.2026.114988_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2025.103379","article-title":"Treg fitness signatures as a biomarker for disease activity in Juvenile Idiopathic Arthritis","volume":"152","author":"Attrill","year":"2025","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.isci.2026.114988_bib65","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s40618-025-02557-w","article-title":"Plasticity deficits of Tregs remodeling toward Th1-like and Th17-like Tregs in individuals with type 1 diabetes","volume":"48","author":"Qin","year":"2025","journal-title":"J. Endocrinol. Investig."},{"key":"10.1016\/j.isci.2026.114988_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103240","article-title":"Peroxynitrite reduces Treg cell expansion and function by mediating IL-2R nitration and aggravates multiple sclerosis pathogenesis","volume":"75","author":"Wu","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.isci.2026.114988_bib67","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01752-2023","article-title":"LPG 18:0 is a general biomarker of asthma and inhibits the differentiation and function of regulatory T-cells","volume":"64","author":"Aili","year":"2024","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.isci.2026.114988_bib68","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.4049\/jimmunol.1302966","article-title":"Inflammation and lymphopenia trigger autoimmunity by suppression of IL-2-controlled regulatory T cell and increase of IL-21-mediated effector T cell expansion","volume":"193","author":"Chevalier","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.isci.2026.114988_bib69","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12974-023-02760-7","article-title":"Tregs dysfunction aggravates postoperative cognitive impairment in aged mice","volume":"20","author":"Zhou","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.isci.2026.114988_bib70","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1172\/JCI85309","article-title":"CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients","volume":"126","author":"Turtle","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.isci.2026.114988_bib71","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.cmet.2019.11.021","article-title":"Mitochondrial integrity regulated by lipid metabolism is a cell-intrinsic checkpoint for Treg suppressive function","volume":"31","author":"Field","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.isci.2026.114988_bib72","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s41467-023-44391-9","article-title":"FOXP3(+) regulatory T cell perturbation mediated by the IFNgamma-STAT1-IFITM3 feedback loop is essential for anti-tumor immunity","volume":"15","author":"Liu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.114988_bib73","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nature07674","article-title":"Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses","volume":"458","author":"Zheng","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.114988_bib74","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aao6923","article-title":"RORalpha-expressing T regulatory cells restrain allergic skin inflammation","volume":"3","author":"Malhotra","year":"2018","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.isci.2026.114988_bib75","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.immuni.2024.01.009","article-title":"Amphiregulin from regulatory T cells promotes liver fibrosis and insulin resistance in non-alcoholic steatohepatitis","volume":"57","author":"Savage","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2026.114988_bib76","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.immuni.2025.01.006","article-title":"Recirculating regulatory T cells mediate thymic regeneration through amphiregulin following damage","volume":"58","author":"Lemarquis","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2026.114988_bib77","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/s12265-022-10290-5","article-title":"The role of regulatory T cells in heart repair after myocardial infarction","volume":"16","author":"Wang","year":"2023","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.isci.2026.114988_bib78","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.7150\/thno.68437","article-title":"CD4(+)FoxP3(+)CD73(+) regulatory T cell promotes cardiac healing post-myocardial infarction","volume":"12","author":"Zhuang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.isci.2026.114988_bib79","doi-asserted-by":"crossref","DOI":"10.1038\/srep13938","article-title":"Transfer of regulatory T cells into abortion-prone mice promotes the expansion of uterine mast cells and normalizes early pregnancy angiogenesis","volume":"5","author":"Woidacki","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.114988_bib80","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.123919","article-title":"IL-33-mediated IL-13 secretion by ST2+ Tregs controls inflammation after lung injury","volume":"4","author":"Liu","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.isci.2026.114988_bib81","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.immuni.2018.07.015","article-title":"Regulatory T cells promote macrophage efferocytosis during inflammation resolution","volume":"49","author":"Proto","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2026.114988_bib82","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1007\/s00262-019-02417-6","article-title":"Regulatory T cells induce CD4(-) NKT cell anergy and suppress NKT cell cytotoxic function","volume":"68","author":"Ihara","year":"2019","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.isci.2026.114988_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114938","article-title":"An IL-2 mutein increases regulatory T cell suppression of dendritic cells via IL-10 and CTLA-4 to promote T cell anergy","volume":"43","author":"Jamison","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2026.114988_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104868","article-title":"Regulatory T cells promote remyelination in the murine experimental autoimmune encephalomyelitis model of multiple sclerosis following human neural stem cell transplant","volume":"140","author":"McIntyre","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.isci.2026.114988_bib85","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.712241","article-title":"The MS remyelinating drug bexarotene (an RXR Agonist) promotes induction of human Tregs and suppresses Th17 differentiation in vitro","volume":"12","author":"Gaunt","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.114988_bib86","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12974-022-02512-z","article-title":"Neuroprotective effects of ex vivo-expanded regulatory T cells on trimethyltin-induced neurodegeneration in mice","volume":"19","author":"Park","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.isci.2026.114988_bib87","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12974-023-02702-3","article-title":"Regulatory T cells decrease C3-positive reactive astrocytes in Alzheimer-like pathology","volume":"20","author":"Stym-Popper","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.isci.2026.114988_bib88","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1189\/jlb.0507296","article-title":"Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson's disease","volume":"82","author":"Reynolds","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.isci.2026.114988_bib89","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1016\/j.neuron.2025.09.001","article-title":"Treg-microglia partnership in the injured spinal cord preserves Treg cell function and regulates microglial cholesterol metabolism","volume":"113","author":"Qin","year":"2025","journal-title":"Neuron"},{"key":"10.1016\/j.isci.2026.114988_bib90","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1158\/0008-5472.CAN-08-2361","article-title":"Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissue","volume":"69","author":"Wieczorek","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2026.114988_bib91","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.clinbiochem.2016.05.019","article-title":"Analytical evaluation of a real-time PCR-based DNA demethylation assay to assess the frequency of naturally occurring regulatory T cells in peripheral blood","volume":"49","author":"Metzker","year":"2016","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.isci.2026.114988_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2021.108847","article-title":"Peripheral blood immune markers in breast cancer: Differences in regulatory T cell abundance are related to clinical parameters","volume":"232","author":"Jorgensen","year":"2021","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.isci.2026.114988_bib93","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1055\/s-0033-1333687","article-title":"Micro-inflammation characterized by disturbed Treg\/Teff balance with increasing sIL-2R in patients with type 2 diabetes","volume":"121","author":"Cai","year":"2013","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.isci.2026.114988_bib94","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1016\/j.ymthe.2021.04.034","article-title":"CAR- and TRuC-redirected regulatory T cells differ in capacity to control adaptive immunity to FVIII","volume":"29","author":"Rana","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.isci.2026.114988_bib95","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1038\/s41591-022-01960-7","article-title":"Post-infusion CAR T(Reg) cells identify patients resistant to CD19-CAR therapy","volume":"28","author":"Good","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2026.114988_bib96","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1038\/s41591-022-01959-0","article-title":"Distinct cellular dynamics associated with response to CAR-T therapy for refractory B cell lymphoma","volume":"28","author":"Haradhvala","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2026.114988_bib97","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1111\/febs.17326","article-title":"Depletion of Tregs from CD4(+) CAR-T cells enhances the tumoricidal effect of CD8(+) CAR-T cells in anti-CD19 CAR-T therapy","volume":"292","author":"Sun","year":"2025","journal-title":"FEBS J."},{"key":"10.1016\/j.isci.2026.114988_bib98","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jtct.2023.04.001","article-title":"Anakinra for refractory cytokine release syndrome or immune effector cell-associated neurotoxicity syndrome after chimeric antigen receptor T cell therapy","volume":"29","author":"Gazeau","year":"2023","journal-title":"Transplant. Cell. Ther."},{"key":"10.1016\/j.isci.2026.114988_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2025.578717","article-title":"Neurotoxicity associated with chimeric antigen receptor T-cell therapy","volume":"407","author":"Wronski","year":"2025","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.isci.2026.114988_bib100","doi-asserted-by":"crossref","first-page":"eadn2404","DOI":"10.1126\/scitranslmed.adn2404","article-title":"A phase 2 randomized trial with autologous polyclonal expanded regulatory T cells in children with new-onset type 1 diabetes","volume":"16","author":"Bender","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.isci.2026.114988_bib101","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jhep.2022.08.035","article-title":"Low dose interleukin-2 selectively expands circulating regulatory T cells but fails to promote liver allograft tolerance in humans","volume":"78","author":"Lim","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.isci.2026.114988_bib102","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/0886022X.2018.1456462","article-title":"Low-dose IL-2 expands CD4(+) regulatory T cells with a suppressive function in vitro via the STAT5-dependent pathway in patients with chronic kidney diseases","volume":"40","author":"Li","year":"2018","journal-title":"Ren. Fail."},{"key":"10.1016\/j.isci.2026.114988_bib103","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.581433","article-title":"Antigen specificity enhances disease control by Tregs in vitiligo","volume":"11","author":"Mukhatayev","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.114988_bib104","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3389\/fimmu.2017.01117","article-title":"Human Tregs made antigen specific by gene modification: the power to treat autoimmunity and antidrug antibodies with precision","volume":"8","author":"Adair","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.114988_bib105","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1182\/blood.2024026446","article-title":"Donor regulatory T-cell therapy to prevent graft-versus-host disease","volume":"145","author":"Meyer","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.isci.2026.114988_bib106","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1182\/bloodadvances.2023011625","article-title":"Single-center randomized trial of T-reg graft alone vs T-reg graft plus tacrolimus for the prevention of acute GVHD","volume":"8","author":"Bader","year":"2024","journal-title":"Blood Adv."},{"key":"10.1016\/j.isci.2026.114988_bib107","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.147474","article-title":"The effect of low-dose IL-2 and Treg adoptive cell therapy in patients with type 1 diabetes","volume":"6","author":"Dong","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.isci.2026.114988_bib108","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.2337\/dc12-0038","article-title":"Administration of CD4+CD25highCD127- regulatory T cells preserves beta-cell function in type 1 diabetes in children","volume":"35","author":"Marek-Trzonkowska","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.isci.2026.114988_bib109","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad4134","article-title":"Type 1 diabetes immunotherapy using polyclonal regulatory T cells","volume":"7","author":"Bluestone","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.isci.2026.114988_bib110","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1263537","article-title":"Regulatory T cells are associated with the tumor immune microenvironment and immunotherapy response in triple-negative breast cancer","volume":"14","author":"Huang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.114988_bib111","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.bbmt.2010.12.710","article-title":"Efficient and selective prevention of GVHD by antigen-specific induced Tregs via linked-suppression in mice","volume":"17","author":"Semple","year":"2011","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.isci.2026.114988_bib112","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5114\/ceji.2023.126773","article-title":"Prognostic values of regulatory T cells (Tregs) and Treg-related genes in gastric cancer","volume":"48","author":"Zheng","year":"2023","journal-title":"Cent. Eur. J. Immunol."},{"key":"10.1016\/j.isci.2026.114988_bib113","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.trsl.2017.06.009","article-title":"Antigen-specific regulatory T cells: are police CARs the answer?","volume":"187","author":"Dawson","year":"2017","journal-title":"Transl. Res."},{"key":"10.1016\/j.isci.2026.114988_bib114","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087722","article-title":"Prevention of allogeneic cardiac graft rejection by transfer of ex vivo expanded antigen-specific regulatory T-cells","volume":"9","author":"Takasato","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2026.114988_bib115","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1212\/01.wnl.0000260269.93245.d2","article-title":"Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial","volume":"68","author":"Lyketsos","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.isci.2026.114988_bib116","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/nm0908-916","article-title":"Anti-inflammatory drugs fall short in Alzheimer's disease","volume":"14","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2026.114988_bib117","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002076","article-title":"Human regulatory T cells with alloantigen specificity are more potent inhibitors of alloimmune skin graft damage than polyclonal regulatory T cells","volume":"3","author":"Sagoo","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.isci.2026.114988_bib118","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1111\/ajt.12433","article-title":"Clinical grade manufacturing of human alloantigen-reactive regulatory T cells for use in transplantation","volume":"13","author":"Putnam","year":"2013","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.isci.2026.114988_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2020.104220","article-title":"Building a CAR-Treg: going from the basic to the luxury model","volume":"358","author":"Rosado-Sanchez","year":"2020","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.isci.2026.114988_bib120","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1002\/ijc.34453","article-title":"A phase 1 trial of NY-ESO-1-specific TCR-engineered T-cell therapy combined with a lymph node-targeting nanoparticulate peptide vaccine for the treatment of advanced soft tissue sarcoma","volume":"152","author":"Ishihara","year":"2023","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.isci.2026.114988_bib121","doi-asserted-by":"crossref","first-page":"8816","DOI":"10.1038\/s41467-024-51897-3","article-title":"Direct recognition of an intact foreign protein by an alphabeta T cell receptor","volume":"15","author":"Almeida","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.114988_bib122","doi-asserted-by":"crossref","first-page":"7189","DOI":"10.1038\/s41467-022-34896-0","article-title":"A class-mismatched TCR bypasses MHC restriction via an unorthodox but fully functional binding geometry","volume":"13","author":"Singh","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.114988_bib123","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1158\/2159-8290.CD-23-1393","article-title":"Rational protein engineering to enhance MHC-independent T-cell receptors","volume":"14","author":"Chang","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.isci.2026.114988_bib124","article-title":"Chimeric antigen receptor costimulation domains modulate human regulatory T cell function","volume":"5","author":"Boroughs","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.isci.2026.114988_bib125","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaut.2018.02.006","article-title":"Engrafting human regulatory T cells with a flexible modular chimeric antigen receptor technology","volume":"90","author":"Koristka","year":"2018","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.isci.2026.114988_bib126","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nm.3838","article-title":"4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors","volume":"21","author":"Long","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2026.114988_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2023.103057","article-title":"Supraphysiological FOXP3 expression in human CAR-Tregs results in improved stability, efficacy, and safety of CAR-Treg products for clinical application","volume":"138","author":"Henschel","year":"2023","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.isci.2026.114988_bib128","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz3866","article-title":"Functional effects of chimeric antigen receptor co-receptor signaling domains in human regulatory T cells","volume":"12","author":"Dawson","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.isci.2026.114988_bib129","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.exphem.2011.08.010","article-title":"Isolation strategies of regulatory T cells for clinical trials: phenotype, function, stability, and expansion capacity","volume":"39","author":"Ukena","year":"2011","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.isci.2026.114988_bib130","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12967-021-03200-x","article-title":"Process development and validation of expanded regulatory T cells for prospective applications: an example of manufacturing a personalized advanced therapy medicinal product","volume":"20","author":"Lavazza","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.isci.2026.114988_bib131","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1186\/s12967-025-06561-9","article-title":"Clinical grade expansion protocol for the manufacture of thymus-derived Treg cells for clinical application","volume":"23","author":"Fanelli","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.isci.2026.114988_bib132","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jaci.2018.07.014","article-title":"Epigenetic mechanisms regulating T-cell responses","volume":"142","author":"Schmidl","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.isci.2026.114988_bib133","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/sj.mt.6300341","article-title":"Generation of potent and stable human CD4+ T regulatory cells by activation-independent expression of FOXP3","volume":"16","author":"Allan","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.isci.2026.114988_bib134","doi-asserted-by":"crossref","first-page":"12258","DOI":"10.1073\/pnas.1922600117","article-title":"Epigenetic conversion of conventional T cells into regulatory T cells by CD28 signal deprivation","volume":"117","author":"Mikami","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2026.114988_bib135","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.cmet.2025.04.008","article-title":"Foxp3 confers long-term efficacy of chimeric antigen receptor-T cells via metabolic reprogramming","volume":"37","author":"Niu","year":"2025","journal-title":"Cell Metab."},{"key":"10.1016\/j.isci.2026.114988_bib136","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.4049\/jimmunol.2100326","article-title":"Lactoferrin potentiates inducible regulatory T cell differentiation through TGF-beta receptor III binding and activation of membrane-bound TGF-beta","volume":"207","author":"Jang","year":"2021","journal-title":"J. Immunol."},{"key":"10.1016\/j.isci.2026.114988_bib137","doi-asserted-by":"crossref","DOI":"10.4110\/in.2023.23.e37","article-title":"Combined treatment with TGF-beta1, retinoic acid, and lactoferrin robustly generate inducible Tregs (iTregs) against high affinity ligand","volume":"23","author":"Jang","year":"2023","journal-title":"Immune Netw."},{"key":"10.1016\/j.isci.2026.114988_bib138","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/s41467-024-45012-9","article-title":"Regulatory T cells use heparanase to access IL-2 bound to extracellular matrix in inflamed tissue","volume":"15","author":"Martinez","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.114988_bib139","article-title":"Receptor-tethered orthogonal IL-2 enhances regulatory T cell therapy","author":"Indart","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.isci.2026.114988_bib140","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2219086120","article-title":"Tonic-signaling chimeric antigen receptors drive human regulatory T cell exhaustion","volume":"120","author":"Lamarche","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2026.114988_bib141","doi-asserted-by":"crossref","first-page":"6446","DOI":"10.1038\/s41467-021-26844-1","article-title":"Transient mTOR inhibition rescues 4-1BB CAR-Tregs from tonic signal-induced dysfunction","volume":"12","author":"Lamarthee","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.114988_bib142","article-title":"CD28 costimulatory domain protects against tonic signaling-induced functional impairment in CAR-Tregs","author":"Lamarth\u00e9e","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.isci.2026.114988_bib143","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1016\/j.ymthe.2023.09.021","article-title":"Arming CAR-T cells with cytokines and more: Innovations in the fourth-generation CAR-T development","volume":"31","author":"Tang","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.isci.2026.114988_bib144","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1126\/science.1160062","article-title":"CTLA-4 control over Foxp3+ regulatory T cell function","volume":"322","author":"Wing","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.isci.2026.114988_bib145","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adx7845","article-title":"Armored human CAR T(reg) cells with PD1 promoter-driven IL-10 have enhanced suppressive function","volume":"11","author":"Boardman","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.isci.2026.114988_bib146","article-title":"Bispecific CAR-T cells targeting FAP and GPC3 have the potential to treat hepatocellular carcinoma","volume":"32","author":"Zhou","year":"2024","journal-title":"Mol. Ther. Oncol."},{"key":"10.1016\/j.isci.2026.114988_bib147","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13045-020-00856-8","article-title":"Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia","volume":"13","author":"Dai","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.isci.2026.114988_bib148","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.3324\/haematol.2012.074088","article-title":"Differential effects of rapamycin and retinoic acid on expansion, stability and suppressive qualities of human CD4(+)CD25(+)FOXP3(+) T regulatory cell subpopulations","volume":"98","author":"Scotta","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.isci.2026.114988_bib149","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1089\/aid.2012.0051","article-title":"High-dose vitamin D3 supplementation is a requisite for modulation of skin-homing markers on regulatory T cells in HIV-infected patients","volume":"29","author":"Khoo","year":"2013","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.isci.2026.114988_bib150","doi-asserted-by":"crossref","first-page":"18465","DOI":"10.1074\/jbc.RA119.011134","article-title":"Glycoengineering of chimeric antigen receptor (CAR) T-cells to enforce E-selectin binding","volume":"294","author":"Mondal","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.isci.2026.114988_bib151","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.669449","article-title":"MRI Guided Focused Ultrasound-Mediated Delivery of Therapeutic Cells to the Brain: A Review of the State-of-the-Art Methodology and Future Applications","volume":"12","author":"Ahmed","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.isci.2026.114988_bib152","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.1021\/acs.jpcb.2c02903","article-title":"How Shockwaves Open Tight Junctions of Blood-Brain Barrier: Comparison of Three Biomechanical Effects","volume":"126","author":"Wei","year":"2022","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.isci.2026.114988_bib153","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1038\/s41417-024-00823-2","article-title":"FGFR4-specific CAR-T cells with inducible caspase-9 suicide gene as an approach to treat rhabdomyosarcoma","volume":"31","author":"Xiao","year":"2024","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.isci.2026.114988_bib154","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.ymthe.2020.10.008","article-title":"Development of CAR T cells expressing a suicide gene plus a chimeric antigen receptor targeting signaling lymphocytic-activation molecule F7","volume":"29","author":"Amatya","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.isci.2026.114988_bib155","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s41434-023-00404-2","article-title":"RapaCaspase-9-based suicide gene applied to the safety of IL-1RAP CAR-T cells","volume":"30","author":"Bouquet","year":"2023","journal-title":"Gene Ther."},{"key":"10.1016\/j.isci.2026.114988_bib156","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2023.101139","article-title":"Lipid nanoparticles outperform electroporation in mRNA-based CAR T cell engineering","volume":"31","author":"Kitte","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.isci.2026.114988_bib157","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1021\/acs.nanolett.9b04246","article-title":"Ionizable lipid nanoparticle-mediated mRNA delivery for human CAR T cell engineering","volume":"20","author":"Billingsley","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.isci.2026.114988_bib158","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1186\/s12967-025-06572-6","article-title":"Chimeric antigen receptors discriminate between tau and distinct amyloid-beta species","volume":"23","author":"Siebrand","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.isci.2026.114988_bib159","doi-asserted-by":"crossref","DOI":"10.3390\/cells12162115","article-title":"Development of beta-amyloid-specific CAR-Tregs for the treatment of Alzheimer's Disease","volume":"12","author":"Saetzler","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.isci.2026.114988_bib160","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s12974-024-03262-w","article-title":"MOG-specific CAR Tregs: a novel approach to treat multiple sclerosis","volume":"21","author":"Frikeche","year":"2024","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.isci.2026.114988_bib161","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1235222","article-title":"CAR-T cells and CAR-Tregs targeting conventional type-1 dendritic cell suppress experimental autoimmune encephalomyelitis","volume":"14","author":"Moorman","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.114988_bib162","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2020.104222","article-title":"Engineered regulatory T cells expressing myelin-specific chimeric antigen receptors suppress EAE progression","volume":"358","author":"De Paula Pohl","year":"2020","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.isci.2026.114988_bib163","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jcyt.2023.11.007","article-title":"Human CD4+CD25+ T cells expressing a chimeric antigen receptor against aberrant superoxide dismutase 1 trigger antigen-specific immunomodulation","volume":"26","author":"Graber","year":"2024","journal-title":"Cytotherapy"},{"key":"10.1016\/j.isci.2026.114988_bib164","doi-asserted-by":"crossref","DOI":"10.3390\/cells14171318","article-title":"Human CAR Tregs Targeting SOD1 and Expressing BDNF Reduce Inflammation and Delay Disease in G93A hSOD1-NSG Mice","volume":"14","author":"Graber","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.isci.2026.114988_bib165","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.psc.2022.07.003","article-title":"Pathophysiology of Alzheimer's disease","volume":"45","author":"Yarns","year":"2022","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.isci.2026.114988_bib166","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41577-024-01104-7","article-title":"Neuroinflammation in Alzheimer disease","volume":"25","author":"Heneka","year":"2025","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.isci.2026.114988_bib167","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10753-022-01721-1","article-title":"Neuroinflammation in Alzheimer's disease: current progress in molecular signaling and therapeutics","volume":"46","author":"Thakur","year":"2023","journal-title":"Inflammation"},{"key":"10.1016\/j.isci.2026.114988_bib168","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.redox.2014.03.002","article-title":"Abeta and tau toxicities in Alzheimer's are linked via oxidative stress-induced p38 activation: protective role of vitamin E","volume":"2","author":"Giraldo","year":"2014","journal-title":"Redox Biol."},{"key":"10.1016\/j.isci.2026.114988_bib169","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/glia.23265","article-title":"A critical role of TRPM2 channel in Abeta(42) -induced microglial activation and generation of tumor necrosis factor-alpha","volume":"66","author":"Alawieyah Syed Mortadza","year":"2018","journal-title":"Glia"},{"key":"10.1016\/j.isci.2026.114988_bib170","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11092394","article-title":"Concordant and discordant cerebrospinal fluid and plasma cytokine and chemokine responses in mild cognitive impairment and early-stage Alzheimer's disease","volume":"11","author":"de la Monte","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.isci.2026.114988_bib171","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1007\/s10787-025-01715-z","article-title":"Interplay between PI3k\/AKT signaling and caspase pathway in Alzheimer disease: mechanism and therapeutic implications","volume":"33","author":"Bhatia","year":"2025","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.isci.2026.114988_bib172","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.4049\/jimmunol.1200947","article-title":"IFN-gamma production by amyloid beta-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease","volume":"190","author":"Browne","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.isci.2026.114988_bib173","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24098026","article-title":"The cytokine CX3CL1 and ADAMs\/MMPs in concerted cross-talk influencing neurodegenerative diseases","volume":"24","author":"Iemmolo","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.114988_bib174","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1038\/s12276-024-01295-y","article-title":"Blockade of STING activation alleviates microglial dysfunction and a broad spectrum of Alzheimer's disease pathologies","volume":"56","author":"Chung","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.isci.2026.114988_bib175","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s12974-021-02308-7","article-title":"CD4+ effector T cells accelerate Alzheimer's disease in mice","volume":"18","author":"Machhi","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.isci.2026.114988_bib176","doi-asserted-by":"crossref","first-page":"8788","DOI":"10.1038\/s41598-019-45433-3","article-title":"The characterization of regulatory T-cell profiles in Alzheimer's disease and multiple sclerosis","volume":"9","author":"Ciccocioppo","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.114988_bib177","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcaa112","article-title":"Restoring regulatory T-cell dysfunction in Alzheimer's disease through ex vivo expansion","volume":"2","author":"Faridar","year":"2020","journal-title":"Brain Commun."},{"key":"10.1016\/j.isci.2026.114988_bib178","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.3389\/fimmu.2018.01213","article-title":"Imbalance of circulating T(h)17 and regulatory T cells in Alzheimer's disease: a case control study","volume":"9","author":"Oberstein","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.114988_bib179","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12974-022-02584-x","article-title":"Neuroinflammation represents a common theme amongst genetic and environmental risk factors for Alzheimer and Parkinson diseases","volume":"19","author":"Boyd","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.isci.2026.114988_bib180","doi-asserted-by":"crossref","first-page":"7967","DOI":"10.1038\/ncomms8967","article-title":"Breaking immune tolerance by targeting Foxp3(+) regulatory T cells mitigates Alzheimer's disease pathology","volume":"6","author":"Baruch","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.114988_bib181","doi-asserted-by":"crossref","first-page":"7668","DOI":"10.7150\/thno.75965","article-title":"Adoptive therapy with amyloid-beta specific regulatory T cells alleviates Alzheimer's disease","volume":"12","author":"Yang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.isci.2026.114988_bib182","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s40478-022-01447-z","article-title":"Ex vivo expanded human regulatory T cells modify neuroinflammation in a preclinical model of Alzheimer's disease","volume":"10","author":"Faridar","year":"2022","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.isci.2026.114988_bib183","article-title":"Therapeutic effects of abeta-specific regulatory T cells in Alzheimer's disease: a study in 5xFAD Mice","volume":"25","author":"Park","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.114988_bib184","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13024-023-00692-7","article-title":"Amyloid-beta specific regulatory T cells attenuate Alzheimer's disease pathobiology in APP\/PS1 mice","volume":"18","author":"Yeapuri","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.isci.2026.114988_bib185","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117721","article-title":"A preclinical and phase I clinical study of ex vivo-expanded amyloid beta-specific human regulatory T cells in Alzheimer's disease","volume":"181","author":"Yang","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.isci.2026.114988_bib186","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a033860","article-title":"Functional amyloids","volume":"11","author":"Otzen","year":"2019","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.isci.2026.114988_bib187","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1016\/j.cell.2021.08.013","article-title":"The expanding amyloid family: structure, stability, function, and pathogenesis","volume":"184","author":"Sawaya","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.isci.2026.114988_bib188","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","article-title":"The epidemiology of Parkinson's disease","volume":"403","author":"Ben-Shlomo","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2026.114988_bib189","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","article-title":"The pathogenesis of Parkinson's disease","volume":"403","author":"Morris","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2026.114988_bib190","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2026.114988_bib191","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/s41593-022-01061-1","article-title":"Single-cell genomic profiling of human dopamine neurons identifies a population that selectively degenerates in Parkinson's disease","volume":"25","author":"Kamath","year":"2022","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.isci.2026.114988_bib192","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.114988_bib193","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s00018-022-04240-2","article-title":"Initiation and progression of alpha-synuclein pathology in Parkinson's disease","volume":"79","author":"Tofaris","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.isci.2026.114988_bib194","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.bbi.2024.02.013","article-title":"Systemic inflammation and risk of Parkinson's disease: A prospective cohort study and genetic analysis","volume":"117","author":"Li","year":"2024","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.isci.2026.114988_bib195","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.bbi.2020.07.005","article-title":"Relationship between circulating CD4+ T lymphocytes and cognitive impairment in patients with Parkinson's disease","volume":"89","author":"Magistrelli","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.isci.2026.114988_bib196","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nature22815","article-title":"T cells from patients with Parkinson's disease recognize alpha-synuclein peptides","volume":"546","author":"Sulzer","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.114988_bib197","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.bbi.2022.01.007","article-title":"Neurodegeneration by alpha-synuclein-specific T cells in AAV-A53T-alpha-synuclein Parkinson's disease mice","volume":"101","author":"Karikari","year":"2022","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.isci.2026.114988_bib198","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.ajhg.2013.10.009","article-title":"Association of Parkinson disease with structural and regulatory variants in the HLA region","volume":"93","author":"Wissemann","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.isci.2026.114988_bib199","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2024.1431079","article-title":"Novel strategies in Parkinson's disease treatment: a review","volume":"17","author":"Mitchell","year":"2024","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.isci.2026.114988_bib200","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.neulet.2010.10.012","article-title":"Granulocyte-colony stimulating factor (G-CSF) enhances recovery in mouse model of Parkinson's disease","volume":"487","author":"Song","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.isci.2026.114988_bib201","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/s12974-022-02685-7","article-title":"Expansion of regulatory T cells by CD28 superagonistic antibodies attenuates neurodegeneration in A53T-alpha-synuclein Parkinson's disease mice","volume":"19","author":"Badr","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.isci.2026.114988_bib202","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s11481-019-09888-5","article-title":"Treg Cells Attenuate Neuroinflammation and Protect Neurons in a Mouse Model of Parkinson's Disease","volume":"15","author":"Huang","year":"2020","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.isci.2026.114988_bib203","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13024-018-0255-7","article-title":"Tolerogenic bone marrow-derived dendritic cells induce neuroprotective regulatory T cells in a model of Parkinson's disease","volume":"13","author":"Schutt","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.isci.2026.114988_bib204","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242015237","article-title":"Alpha-Synuclein-Specific Regulatory T Cells Ameliorate Parkinson's Disease Progression in Mice","volume":"24","author":"Park","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.114988_bib205","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/s41586-023-06300-4","article-title":"Co-transplantation of autologous T(reg) cells in a cell therapy for Parkinson's disease","volume":"619","author":"Park","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.114988_bib206","doi-asserted-by":"crossref","first-page":"S201","DOI":"10.3233\/JPD-223278","article-title":"Therapeutic Strategies for Immune Transformation in Parkinson's Disease","volume":"12","author":"Saleh","year":"2022","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.isci.2026.114988_bib207","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jns.2013.03.002","article-title":"Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination","volume":"333","author":"Rostami","year":"2013","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.isci.2026.114988_bib208","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1474-4422(22)00289-7","article-title":"Multiple sclerosis progression: time for a new mechanism-driven framework","volume":"22","author":"Kuhlmann","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.isci.2026.114988_bib209","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1038\/s41590-022-01360-6","article-title":"Cognate microglia-T cell interactions shape the functional regulatory T cell pool in experimental autoimmune encephalomyelitis pathology","volume":"23","author":"Haimon","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.isci.2026.114988_bib210","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s40263-018-0518-4","article-title":"Beyond the Magic Bullet: Current Progress of Therapeutic Vaccination in Multiple Sclerosis","volume":"32","author":"Willekens","year":"2018","journal-title":"CNS Drugs"},{"key":"10.1016\/j.isci.2026.114988_bib211","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41591-023-02716-7","article-title":"Autoimmune disease is the next frontier for CAR T cell therapy","volume":"30","author":"Arnold","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2026.114988_bib212","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ymthe.2017.09.001","article-title":"Gene Therapy-Induced Antigen-Specific Tregs Inhibit Neuro-inflammation and Reverse Disease in a Mouse Model of Multiple Sclerosis","volume":"26","author":"Keeler","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.isci.2026.114988_bib213","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1742-2094-9-112","article-title":"CAR\/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery","volume":"9","author":"Fransson","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.isci.2026.114988_bib214","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jaut.2018.05.003","article-title":"Engineered MBP-specific human Tregs ameliorate MOG-induced EAE through IL-2-triggered inhibition of effector T cells","volume":"92","author":"Kim","year":"2018","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.isci.2026.114988_bib215","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-075037","article-title":"Advances in molecular pathology, diagnosis, and treatment of amyotrophic lateral sclerosis","volume":"383","author":"Ilieva","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.isci.2026.114988_bib216","doi-asserted-by":"crossref","first-page":"96","DOI":"10.14336\/AD.2023.0519","article-title":"The Inflammatory Puzzle: Piecing together the Links between Neuroinflammation and Amyotrophic Lateral Sclerosis","volume":"15","author":"He","year":"2024","journal-title":"Aging Dis."},{"key":"10.1016\/j.isci.2026.114988_bib217","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41598-021-03891-8","article-title":"SOD1 mutations associated with amyotrophic lateral sclerosis analysis of variant severity","volume":"12","author":"Berdynski","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.114988_bib218","doi-asserted-by":"crossref","DOI":"10.3390\/ijms251910392","article-title":"Rutin Ameliorates ALS Pathology by Reducing SOD1 Aggregation and Neuroinflammation in an SOD1-G93A Mouse Model","volume":"25","author":"Du","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.114988_bib219","doi-asserted-by":"crossref","first-page":"6733","DOI":"10.1038\/s41467-022-34526-9","article-title":"T cell responses at diagnosis of amyotrophic lateral sclerosis predict disease progression","volume":"13","author":"Yazdani","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.114988_bib220","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12051022","article-title":"Induction of FoxP3 Pre-mRNA Alternative Splicing to Enhance the Suppressive Activity of Regulatory T Cells from Amyotrophic Lateral Sclerosis Patients","volume":"12","author":"Zhdanov","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.isci.2026.114988_bib221","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/brain\/awr074","article-title":"Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis","volume":"134","author":"Beers","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.isci.2026.114988_bib222","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200019","article-title":"Combined Regulatory T-Lymphocyte and IL-2 Treatment Is Safe, Tolerable, and Biologically Active for 1 Year in Persons With Amyotrophic Lateral Sclerosis","volume":"9","author":"Thonhoff","year":"2022","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.isci.2026.114988_bib223","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abe7378","article-title":"SynNotch-CAR T cells overcome challenges of specificity, heterogeneity, and persistence in treating glioblastoma","volume":"13","author":"Choe","year":"2021","journal-title":"Sci. Transl. Med."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226003639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226003639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:28:01Z","timestamp":1788949681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226003639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":223,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2589004226003639"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.114988","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CAR Treg therapies for neurodegenerative diseases","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.114988","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"114988"}}